| Current and emerging drug treatment options for Alzheimer’s disease: a systematic review N Herrmann, SA Chau, I Kircanski, KL Lanctot Drugs 71, 2031-2065, 2011 | 312 | 2011 |
| Dermal permeation data and models for the prioritization and screening-level exposure assessment of organic chemicals TN Brown, JM Armitage, P Egeghy, I Kircanski, JA Arnot Environment international 94, 424-435, 2016 | 35 | 2016 |
| Develop Sub-Module for Direct Human Exposures to Consumer Products JA Arnot, X Zhang, I Kircanski, L Hughes, J Armitage Technical Report for the US Environmental Protection Agency, 0 | 10 | |
| Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies RD Wegrzyn, AS Rudolph CRC Press, 2012 | 7 | 2012 |
| Clinical decisions following implementation of asparaginase activity monitoring in pediatric patients with acute lymphoblastic leukemia: Experience from a single‐center study K Nadeem, D Colantonio, I Kircanski, A Naqvi, J Hitzler, JA Whitlock, ... Pediatric Blood & Cancer 67 (2), e28044, 2020 | 4 | 2020 |
| Krista L. Lanctôt, Ida Kircanski, Sarah A Chau, N Herrmann Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic …, 2012 | | 2012 |
